LSU Health Research suggests novel combination therapy for triple-negative breast cancer - EurekAlert

Research led by Suresh Alahari, PhD, Professor of Biochemistry at LSU Health New Orleans schools of Medicine and Graduate Studies, suggests a combination of drugs already approved by the FDA for other cancers may be effective in treating chemo-resistant tripl…

New Orleans, LA – Research led by Suresh Alahari, PhD, Professor of Biochemistry at LSU Health New Orleans schools of Medicine and Graduate Studies, suggests a combination of drugs already approved b… [+4078 chars]

full article...